Owners, management and financials
CVR: 41812052
DKK 13,561,646
Gross profit
Net result: DKK 804,031
Jakob SK Holding ApS (33,33-49,99%), E.B.J Holding ApS (33,33-49,99%)
1 more
CVR · view owners
Emil Birk Johannsen, Jakob Flinch Skovbjerg
Board: Steen Ulf Jensen (chair) and 4 members
CVR · view management
Active
Founded 2 November 2020
CVR · view overview
61 employees
CVR · 2026
Owner registered: Strive Ventures Fund 2 K/S
CVR · 31/03/2025
View the full event history
Epione Medicine ApS is a Danish company of the type Anpartsselskab based in Hvidovre, founded in 2020. The company is registered under the industry Engroshandel med medicinalvarer og sygeplejeartikler. The management consists of Emil Birk Johannsen and Jakob Flinch Skovbjerg. The board consists of Steen Ulf Jensen (chair), Emil Birk Johannsen, Jakob Flinch Skovbjerg and Leon Svejgaard Pedersen. The company is owned by Jakob SK Holding ApS, E.B.J Holding ApS and Strive Ventures Fund 2 K/S. The company has 61 employees (2026). In 2025, the company reported a gross profit of DKK 13,561,646 and a net result of DKK 804,031 compared with DKK 19,045,217 the year before. Equity in the 2025 report amounted to DKK 7,377,972.
Source: annual report 2025, Danish Business Authority
The financial health of Epione Medicine ApS shows a fluctuating trajectory, with significant gross profit variations over the past few years. In 2024, the company achieved a gross profit of 31,344,464 DKK and a profit of 19,045,217 DKK, indicating a strong recovery from a loss of 648,632 DKK in 2023. However, the equity position has declined from 19,073,941 DKK in 2024 to 7,377,972 DKK in 2025, raising concerns about sustainability. The absence of disclosed revenue figures makes it challenging to assess overall market position, but the substantial gross profits suggest a competitive edge in the pharmaceutical and healthcare supplies sector.
AI-generated summary · Generated 14/08/2026
Virksomhedens formål er engroshandel med medicinalvarer
Source: annual reports filed with the Danish Business Authority.
| Period | Gross Profit | Profit/Loss | Total Assets | Equity | Employees | Report |
|---|---|---|---|---|---|---|
| 202501/01/2025 – 31/12/2025 | 13.6 mio. | 804 t. | 34.4 mio. | 7.4 mio. | 24 | |
| 202401/01/2024 – 31/12/2024 | 31.3 mio. | 19 mio. | 48.3 mio. | 19.1 mio. | 12 | |
| 202301/03/2023 – 31/12/2023 | 2.6 mio. | -649 t. | 8.6 mio. | 29 t. | 6 | |
| 202301/03/2022 – 28/02/2023 | 2.3 mio. | 810 t. | 4.3 mio. | 827 t. | 3 |
Compared to 404 companies in Engroshandel med medicinalvarer og sygeplejeartikler
Comparison is based on industry median values
Screen owners and management against the Danish FSA's official PEP lists
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreThe CVR number of Epione Medicine ApS is 41812052.
Epione Medicine ApS is owned by Jakob SK Holding ApS, E.B.J Holding ApS and Strive Ventures Fund 2 K/S.
The management of Epione Medicine ApS consists of Emil Birk Johannsen and Jakob Flinch Skovbjerg.
The board of Epione Medicine ApS consists of Steen Ulf Jensen, Emil Birk Johannsen and Jakob Flinch Skovbjerg, with Steen Ulf Jensen as chair.
In 2025, Epione Medicine ApS reported a gross profit of DKK 13,561,646.
Epione Medicine ApS had 61 employees in 2026 according to the Danish CVR register.
Claim this page to add your logo and social links. Free to get started.
Epione Medicine ApS has published its annual report for 2025. Gross profit came to DKK 13,561,646, and the net result was DKK 804,031.
Contact info changed: new phone: 28603833, new email: [email protected], new website: Epionemedicine.com (April 13, 2026).
Contact info changed: new phone: 28603833, new email: [email protected], new website: Epionemedicine.com (April 13, 2026).
As of April 9, 2026, Nikolaj Friis Krøyer has joined the board of directors of Epione Medicine ApS.
Contact info changed: new phone: 28603833, new email: [email protected], new website: Epionemedicine.com (January 29, 2026).
As of July 1, 2025, Steen Ulf Jensen has joined the board of directors of Epione Medicine ApS.
Epione Medicine ApS has published its annual report for 2024. Gross profit came to DKK 31,344,464, and the net result was DKK 19,045,217.
As of March 31, 2025, Leon Svejgaard Pedersen has joined the board of directors of Epione Medicine ApS.
As of March 31, 2025, Jakob Flinch Skovbjerg has joined the board of directors of Epione Medicine ApS.
As of March 31, 2025, Emil Birk Johannsen has joined the board of directors of Epione Medicine ApS.
As of March 31, 2025, Strive Ventures Fund 2 K/S is registered as an owner of Epione Medicine ApS with an ownership share of 20%.
Epione Medicine ApS has published its interim report for the period March 1, 2023 – December 31, 2023.
As of April 16, 2024, Kreston SR STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Epione Medicine ApS.
Epione Medicine ApS has published its annual report for 2023. Gross profit came to DKK 2,307,030, and the net result was DKK 810,112.
Epione Medicine ApS has published its interim report for the period November 2, 2020 – February 28, 2022.
As of January 24, 2022, Jakob Flinch Skovbjerg is registered as director of Epione Medicine ApS.
As of January 21, 2022, Jakob SK Holding ApS is registered as an owner of Epione Medicine ApS with an ownership share of 33%.
As of January 21, 2022, E.B.J Holding ApS is registered as an owner of Epione Medicine ApS with an ownership share of 33%.
As of January 10, 2021, Kreston SR STATSAUTORISERET REVISIONSPARTNERSELSKAB has stepped down as auditor of Epione Medicine ApS.
As of November 2, 2020, Kreston SR STATSAUTORISERET REVISIONSPARTNERSELSKAB has been appointed auditor of Epione Medicine ApS.
As of November 2, 2020, Emil Birk Johannsen is registered as adm. dir. of Epione Medicine ApS.
Epione Medicine ApS was founded on November 2, 2020.
Companies in the same industry and area
CVR 43211749
CVR 44015706
CVR 36089210
CVR 30279417
CVR 46414829
